ALKERMES PHARMA IRELAND LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 17993
 
  
 
C07D HETEROCYCLIC COMPOUNDS 31131
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 15123
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 14140
 
  
 
B02C CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN 926
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 788
 
  
 
B01J CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 6103
 
  
 
C07K PEPTIDES 6130
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 346
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 367

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0055,774 SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONNov 02, 17Mar 01, 18[A61K]
2017/0000,783 Multiparticulate Modified Release CompositionJun 27, 16Jan 05, 17[A61K]
2016/0318,869 Heterocyclic Compounds for the Treatment of Neurological and Psychological DisordersMay 05, 16Nov 03, 16[C07F, C07D]
2016/0228,376 MONOMETHYLFUMARATE PRODRUG COMPOSITIONSFeb 08, 16Aug 11, 16[A61K]
2010/0272,796 SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONNov 25, 09Oct 28, 10[A61K, A61P]
2006/0240,105 Multiparticulate modified release compositionMar 10, 06Oct 26, 06[A61K]
2004/0197,405 Multiparticulate modified release compositionApr 19, 04Oct 07, 04[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9918978 Compositions of buprenorphine and μ antagonistsMar 10, 16Mar 20, 18[A61K]
9913837 Compositions of buprenorphine and μ antagonistsSep 12, 16Mar 13, 18[A61K]
9861699 Pharmaceutical compositions having improved storage stabilityOct 13, 15Jan 09, 18[A61K, C07D]
9827240 Polymorphic forms of naltrexoneDec 16, 16Nov 28, 17[A61K, C07D]
9775823 Prodrugs of fumarates and their use in treating various diseasesOct 17, 16Oct 03, 17[A61K, C07D]
9682936 Morphan and morphinan analogues, and methods of useJul 21, 16Jun 20, 17[A61K, C07D]
9670200 Quaternary ammonium salt prodrugsDec 23, 10Jun 06, 17[A61K, C07F, C07D]
9656961 Methods for treating depressive symptomsMay 23, 14May 23, 17[A61K, C07D]
9650341 Process for synthesizing oxidized lactam compoundsJul 24, 15May 16, 17[C07F, C07D]
9604922 Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseasesFeb 24, 15Mar 28, 17[C07D, C07C]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0038,508 PHARMACEUTICAL COMPOSITIONS COMPRISING SORBITAN ESTERSAbandonedApr 16, 15Feb 11, 16[A61K]
2015/0320,682 NANOPARTICULATE MEGESTROL FORMULATIONSAbandonedMay 15, 15Nov 12, 15[A61K]
2015/0216,822 NANOPARTICULATE CINACALCET COMPOSITIONSAbandonedApr 17, 15Aug 06, 15[A61K]
9044396 Nanoparticulate megestrol formulationsWithdrawnJun 29, 04Jun 02, 15[A61K]
2014/0248,341 ALCOHOL RESISTANT ENTERIC PHARMACEUTICAL COMPOSITIONSAbandonedApr 29, 14Sep 04, 14[A61K]
2014/0193,507 PREPARATION OF INJECTABLE SUSPENSIONS HAVING IMPROVED INJECTABILITYAbandonedNov 20, 13Jul 10, 14[A61K]
2014/0155,424 NALTREXONE LONG ACTING FORMULATIONS AND METHODS OF USEAbandonedApr 26, 13Jun 05, 14[A61K]
2014/0031,281 POLYMER-BASED SUSTAINED RELEASE DEVICEAbandonedMay 10, 13Jan 30, 14[A61K]
2014/0018,397 Sustained Release Aminopyridine CompositionAbandonedSep 12, 13Jan 16, 14[A61K]
2013/0309,310 Injectable Nanoparticulate Olanzapine FormulationsAbandonedJul 24, 13Nov 21, 13[A61K]
2013/0251,805 LOW VISCOSITY LIQUID DOSAGE FORMSAbandonedDec 07, 12Sep 26, 13[A61K]
2013/0079,747 DRUG DELIVERY DEVICEAbandonedSep 14, 12Mar 28, 13[A61M]
2013/0045,276 SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONAbandonedAug 14, 12Feb 21, 13[A61K, A61P]
8367112 Nanoparticulate carverdilol formulationsExpiredFeb 28, 06Feb 05, 13[A61K]
2013/0011,447 CONTROLLED RELEASE NANOPARTICULATE COMPOSITIONSAbandonedSep 14, 12Jan 10, 13[A61K, B82Y]
2013/0012,872 DRUG DELIVERY DEVICEAbandonedSep 14, 12Jan 10, 13[A61M]
2013/0012,874 DRUG DELIVERY DEVICEAbandonedSep 14, 12Jan 10, 13[B23P, A61M]
2013/0012,875 DRUG DELIVERY DEVICEAbandonedSep 14, 12Jan 10, 13[A61M]
2012/0315,336 INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONSAbandonedMay 03, 12Dec 13, 12[A61K, B82Y, A61P]
2012/0213,829 DRY POWDER AEROSOLS OF NANOPARTICULATE DRUGSAbandonedFeb 24, 12Aug 23, 12[A61K, B82Y, B82B, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.